Circulating human microRNAs are not linked to JC polyomavirus serology or urinary viral load in healthy subjects

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Lagatie, Ole ^a   Van Loy, Tom ^a   Tritsmans, Luc ^b   Stuyver, Lieven J ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Circulating microRNA; JC polyomavirus; microRNA; Plasma; Serology; Viral load

Indexed keywords

MICRORNA; VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; FEMALE; HUMAN; HUMAN TISSUE; JC POLYOMAVIRUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; POLYOMA VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; URINALYSIS; VIRUS LOAD; YOUNG ADULT;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; JC VIRUS; MALE; MICRORNAS; MIDDLE AGED; PLASMA; POLYOMAVIRUS INFECTIONS; URINE; VIRAL LOAD; YOUNG ADULT;

EID: 84896142047     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-41     Document Type: Article

References (42)

1. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, Major EO, Clin Microbiol Rev 2012 25 3 471 506 10.1128/CMR.05031-11 22763635
2. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies. Bellizzi A, Nardis C, Anzivino E, Rodio D, Fioriti D, Mischitelli M, Chiarini F, Pietropaolo V, J Neurovirol 2012 18 1 1 11 10.1007/s13365-012-0080-7 22290500
3. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. Markowitz RB, Thompson HC, Mueller JF, Cohen JA, Dynan WS, J Infect Dis 1993 167 1 13 20 10.1093/infdis/167.1.13 8380288
4. Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. Tan CS, Dezube BJ, Bhargava P, Autissier P, Wuthrich C, Miller J, Koralnik IJ, J Infect Dis 2009 199 6 881 888 10.1086/597117 19434914
5. Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier. Chapagain ML, Nerurkar VR, J Infect Dis 2010 202 2 184 191 10.1086/653823 20550458
6. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, Miller E, J Med Virol 2003 71 1 115 123 10.1002/jmv.10450 12858417
7. A second-generation ELISA (STRATIFY JCV DxSelect) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. Lee P, Plavina T, Castro A, Berman M, Jaiswal D, Rivas S, Schlain B, Subramanyam M, J Clin Virol 2013 57 2 141 146 10.1016/j.jcv.2013.02.002 23465394
8. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Major EO, Annu Rev Med 2010 61 35 47 10.1146/annurev.med.080708.082655 19719397
9. Quasispecies analysis of JC virus DNA present in urine of healthy subjects. Van Loy T, Thys K, Tritsmans L, Stuyver LJ, PLoS One 2013 8 8 70950 10.1371/journal.pone.0070950 23967139
10. More on JC viremia in natalizumab-treated patients with multiple sclerosis. Major EO, Frohman E, Douek D, N Engl J Med 2013 369 13 1280 10.1056/NEJMc1213681
11. JC viremia in natalizumab-treated patients with multiple sclerosis. Major EO, Frohman E, Douek D, N Engl J Med 2013 368 23 2240 2241 10.1056/NEJMc1214233 23738566
12. An antibody response to human polyomavirus 15-mer peptides is highly abundant in healthy human subjects. Stuyver LJ, Verbeke T, Van Loy T, Van Gulck E, Tritsmans L, Virol J 2013 10 192 10.1186/1743-422X-10-192 23758776
13. Asymptomatic reactivation of JC virus in patients treated with natalizumab. Chen Y, Bord E, Tompkins T, Miller J, Tan CS, Kinkel RP, Stein MC, Viscidi RP, Ngo LH, Koralnik IJ, N Engl J Med 2009 361 11 1067 1074 10.1056/NEJMoa0904267 19741227
14. JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Viscidi RP, Khanna N, Tan CS, Li X, Jacobson L, Clifford DB, Nath A, Margolick JB, Shah KV, Hirsch HH, Koralnik IJ, Clin Infect Dis 2011 53 7 711 715 10.1093/cid/cir507 21852452
15. MicroRNAs: small RNAs with a big role in gene regulation. He L, Hannon GJ, Nat Rev Genet 2004 5 7 522 531 10.1038/nrg1379 15211354
16. Viral miRNAs: tools for immune evasion. Boss IW, Renne R, Curr Opin Microbiol 2010 13 4 540 545 10.1016/j.mib.2010.05.017 20580307
17. Virus-encoded microRNAs: an overview and a look to the future. Kincaid RP, Sullivan CS, PLoS Pathog 2012 8 12 1003018 10.1371/journal.ppat.1003018 23308061
18. A blood based 12-miRNA signature of Alzheimer disease patients. Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, Haas J, Ruprecht K, Paul F, Stahler C, Lang CJ, Meder B, Bartfai T, Meese E, Keller A, Genome Biol 2013 14 7 78 10.1186/gb-2013-14-7-r78 23895045
19. Circulating microRNAs as novel biomarkers for diabetes mellitus. Guay C, Regazzi R, Nat Rev Endocrinol 2013 9 9 513 521 10.1038/nrendo.2013.86 23629540
20. Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures. Madhavan D, Cuk K, Burwinkel B, Yang R, Front Genet 2013 4 116 23802013
21. Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection. Kawano Y, Iwata S, Kawada J, Gotoh K, Suzuki M, Torii Y, Kojima S, Kimura H, Ito Y, J Infect Dis 2013 208 5 771 779 10.1093/infdis/jit222 23687223
22. microRNAs in circulation are altered in response to influenza A virus infection in humans. Tambyah PA, Sepramaniam S, Mohamed Ali J, Chai SC, Swaminathan P, Armugam A, Jeyaseelan K, PLoS One 2013 8 10 76811 10.1371/journal.pone.0076811 24116168
23. Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. Winther TN, Bang-Berthelsen CH, Heiberg IL, Pociot F, Hogh B, PLoS One 2013 8 3 58236 10.1371/journal.pone. 0058236 23469271
24. Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis. Shwetha S, Gouthamchandra K, Chandra M, Ravishankar B, Khaja MN, Das S, Sci Rep 2013 3 1555 23549102
25. The miRNA world of polyomaviruses. Lagatie O, Tritsmans L, Stuyver LJ, Virol J 2013 10 268 10.1186/1743-422X-10-268 23984639
26. Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma. Plavina T, Berman M, Njenga M, Crossman M, Lerner M, Gorelik L, Simon K, Schlain B, Subramanyam M, J Clin Virol 2012 53 1 65 71 10.1016/j.jcv.2011.10.003 22104399
27. High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Mestdagh P, Feys T, Bernard N, Guenther S, Chen C, Speleman F, Vandesompele J, Nucleic Acids Res 2008 36 21 143 10.1093/nar/gkn725 18940866
28. miRNA expression profiling: from reference genes to global mean normalization. D'Haene B, Mestdagh P, Hellemans J, Vandesompele J, Meth Mol Biol 2012 822 261 272 10.1007/978-1-61779-427-8-18
29. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Benjamini Y, Hochberg Y, J Roy Stat Soc B 1995 57 1 289 300
30. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. Antonsson A, Green AC, Mallitt KA, O'Rourke PK, Pawlita M, Waterboer T, Neale RE, J Gen Virol 2010 91 Pt 7 1849 1853 20219899
31. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH, J Infect Dis 2009 199 6 837 846 10.1086/597126 19434930
32. Genotyping of the JC virus in urine samples of healthy Korean individuals. Jeong BH, Lee KH, Choi EK, Kim K, Kim YS, J Med Virol 2004 72 2 281 289 10.1002/jmv.10568 14695671
33. How does multiple testing correction work? Noble WS, Nat Biotechnol 2009 27 12 1135 1137 10.1038/nbt1209-1135 20010596
34. Human polyomaviruses in disease and cancer. Dalianis T, Hirsch HH, Virology 2013 437 2 63 72 10.1016/j.virol.2012.12.015 23357733
35. A cornucopia of human polyomaviruses. DeCaprio JA, Garcea RL, Nat Rev Microbiol 2013 11 4 264 276 10.1038/nrmicro2992 23474680
36. Identification of a novel human polyomavirus in organs of the gastrointestinal tract. Korup S, Rietscher J, Calvignac-Spencer S, Trusch F, Hofmann J, Moens U, Sauer I, Voigt S, Schmuck R, Ehlers B, PLoS One 2013 8 3 58021 10.1371/journal.pone.0058021 23516426
37. Genome analysis of the new human polyomaviruses. Van Ghelue M, Khan MT, Ehlers B, Moens U, Rev Med Virol 2012 22 6 354 377 10.1002/rmv.1711 22461085
38. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Zaragosi LE, Wdziekonski B, Brigand KL, Villageois P, Mari B, Waldmann R, Dani C, Barbry P, Genome Biol 2011 12 7 64 10.1186/gb-2011-12-7-r64 21767385
39. Regulation of microRNA expression and abundance during lymphopoiesis. Kuchen S, Resch W, Yamane A, Kuo N, Li Z, Chakraborty T, Wei L, Laurence A, Yasuda T, Peng S, Hu-Li J, Lu K, Dubois W, Kitamura Y, Charles N, Sun HW, Muljo S, Schwartzberg PL, Paul WE, O'Shea J, Rajewsky K, Casellas R, Immunity 2010 32 6 828 839 10.1016/j.immuni.2010.05.009 20605486
40. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Farazi TA, Horlings HM, Ten Hoeve JJ, Mihailovic A, Halfwerk H, Morozov P, Brown M, Hafner M, Reyal F, van Kouwenhove M, Kreike B, Sie D, Hovestadt V, Wessels LF, van de Vijver MJ, Tuschl T, Canc Res 2011 71 13 4443 4453 10.1158/0008-5472.CAN-11-0608
41. Isolation of microarray-grade total RNA, microRNA, and DNA from a single PAXgene blood RNA tube. Kruhoffer M, Dyrskjot L, Voss T, Lindberg RL, Wyrich R, Thykjaer T, Orntoft TF, J Mol Diagn 2007 9 4 452 458 10.2353/jmoldx.2007.060175 17690207
42. Blood-based miRNA preparation for noninvasive biomarker development. Debey-Pascher S, Chen J, Voss T, Staratschek-Jox A, Meth Mol Biol 2012 822 307 338 10.1007/978-1-61779-427-8-22